A round-up of recent developments in the contract research sector, including updates from Parexel, Medpace, Clinipace, Synexus and ERT.
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

